¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"anterior sinus group"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • group medicine
    Áý´ÜÁø·á, Çùµ¿Áø·á
  • group practice
    Áý´Ü°³¿ø, Áý´Ü°³¾÷
  • group psychotherapy
    Áý´ÜÁ¤½Å¿ä¹ý
  • group reference value
    Áý´ÜÂü°íÄ¡
  • group-specific
    ±ºÆ¯ÀÌ-
  • group-specific antigen
    ¹«¸®Æ¯ÀÌÇ׿ø, ±ºÆ¯ÀÌÇ׿ø
  • high risk group
    °íÀ§Ç豺
  • haptenic group
    ºÒ¿ÏÀüÇ׿ø±º, ÇÕÅÙ±º
  • linkage group
    ¿¬°ü±º
  • low risk group
    ÀúÀ§Ç豺
  • methyl group
    ¸ÞÆ¿±â
  • osmophore group
    ¹ßÇâ´Ü(Û¡úÅÓ¥)
  • prosthetic group
    1. º¸°áºÐÀÚ´Ü 2. º¸°á¿øÀÚ´Ü
  • Rh blood group system
    RhÇ÷¾×Çüü°è
  • soluble group
    °¡¿ëÇØ±º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • group fascicular repair
    ½Å°æ¼¶À¯´Ù¹ß±ººÀÇÕ(¹ý)
  • group reference value
    Áý´Ü±âÁØÄ¡
  • haptenic group
    ºÒ¿ÏÀüÇ׿ø±º, ÇÕÅÙ±º
  • high risk group
    °íÀ§Çèµµ±º
  • index group
    ÃʹßȯÀÚ±º
  • labile methyl group
    ºÒ¾ÈÁ¤¸ÞÆ¿±â
  • linkage group
    ¿¬°ü±º
  • marathon group
    ¸¶¶óÅæÁý´Ü
  • methyl group
    ¸ÞÆ¿±â
  • minority group
    ¼Ò¼öÁý´Ü
  • nonionic polar group
    ºñÀ̿±ؼº±â
  • open group
    °ø°³Áý´Ü, °³¹æÁý´Ü
  • osmophore group
    ¹ßÇâ´Ü
  • prosthetic group
    ¹èÇÕ±º
  • self-help group
    ÀÚÁ¶Áý´Ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • ABO blood group=ABO system
    ABO Ç÷¾×Çü
  • Coxsackie group A
    ÄÛ»èŰ A±º.
  • Coxsackie group B
    ÄÛ»èŰ B±º.
  • Diego blood group system
    µð¿¡°í Ç÷¾×Çü°è
  • GCR= group conformity rating
    Áý´ÜÇÕÄ¡ µî±ÞºÐ·ù.
  • Gag => group specifiic antigen/core
    ±×·ì<±º>ƯÀ̼º Ç׿ø/ÄÚ¾î
  • Kell blood group system
    ÄÌÇ÷¾×Çü±º
  • Kidd blood group system
    ۵åÇ÷¾×Çü±º
  • Lewis blood group system
    ·çÀ̽º Ç÷¾×Çü±º
  • Lutheran blood group system
    ·çÅͶõ Ç÷¾×Çü±º
  • P blood group system
    PÇ÷¾×Çü±º
  • Rh blood group
    RhÇ÷¾×Çü.
  • Rh blood group
    Rh Ç÷¾×Çü
  • Rh blood group system
    Rh Ç÷¾×Çü±º
  • amino group
    ¾Æ¹Ì³ë±â(¡­Ðñ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • group discussion
    Áý´ÜÅäÀÇ(̤ËÀ̬Ëö).
  • group displacement law
    Áý´Üº¯À§¹ýÄ¢(ÊÙËÒ ËôËÑ̬).
  • group dynamics
    Áý´Ü¿ªÇÐ(ÊÙËç ).
  • group file
    ±×·ì È­ÀÏ
  • group hearing aid
    Áý´Üº¸Ã»±â
  • group hospital
    º´¿øÁ¶ÇÕ(ËÓËô̡̰).
  • group incompatibility
    Ç÷¾×±ººÎÀûÇÕ(úìäûÏØ ÝÕîêùê).
  • group medicine
    Áý´Ü<Çùµ¿>Áø·á.
  • group of isogenous chondrocyte
    ¿¬°ñ¼¼Æ÷¹«¸®
  • group of muscles
    ±ÙÀ°¹«¸®, ±Ù±º(ÐÉÏØ).
  • group of muscles
    ±ÙÀ°¹«¸®, ±Ù__ÐÉÏØ).
  • group practice
    Áý´Ü°³¾÷(̤ËÀ˧ ).
  • group psychotherapy
    Áý´ÜÁ¤½ÅÄ¡·á(ó¢Ó¥ïñãêö½Öû)(¿ä¹ý)
  • group reaction
    Áý´Ü¹ÝÀÀ(̤ËÀËÑËô).
  • group reference value
    Áý´Ü±âÁØ<--ÂüÁ¶>Ä¡
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Anal sinus
    Ç×¹®µ¿±¼
    [¿¾ ¿ë¾î] Ç×¹®µ¿
  • Intercavernous sinus
    ÇØ¸é»çÀÌÁ¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] ÇØ¸é°£Á¤¸Æµ¿
  • Carvenous sinus
    ÇØ¸éÁ¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] ÇØ¸éÁ¤¸Æµ¿
  • Sinus of pulmonary trunk
    ÇãÆÄµ¿¸Æµ¿±¼
    [¿¾ ¿ë¾î] Æóµ¿¸Æµ¿
  • Sigmoid sinus
    ±¸ºÒÁ¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] s»óÁ¤¸Æµ¿
  • Groove for sigmoid sinus
    ±¸ºÒÁ¤¸Æµ¿±¼°í¶û
    [¿¾ ¿ë¾î] ¿¡½º»óµ¿±¸
  • Sinus
    µ¿±¼
    [¿¾ ¿ë¾î] µ¿
  • Sinus
    µ¿±¼
    [¿¾ ¿ë¾î] Á¶µ¿
  • Sinus tubercle
    µ¿±¼°áÀý
    [¿¾ ¿ë¾î] µ¿°áÀý
  • Posterior sinus
    µÚµ¿±¼
    [¿¾ ¿ë¾î] Èĵ¿
  • Sinus of duct
    ¹èÃâ°üµ¿±¼
    [¿¾ ¿ë¾î] °üµ¿
  • Sinus of epididymis
    ºÎ°íȯµ¿±¼
    [¿¾ ¿ë¾î] ºÎ°íȯµ¿
  • Oblique sinus
    ½ÉÀ帷ºøµ¿±¼
    [¿¾ ¿ë¾î] ½É¸·»çµ¿
  • Sinus venosus
    Á¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] Á¤¸Æµ¿
  • Venous sinus
    Á¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] Á¤¸Æµ¿
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • neuraminosyl group
    ´º¶ó¹Ì³ë½Ç±â(Ðñ)
  • neuroaminoyl group
    ´º·Î¾Æ¹Ì³ëÀϱâ(Ðñ)
  • nitroso group
    ³ªÀÌÆ®·Î¼Ò±â(Ðñ)
  • P blood group
    P Ç÷¾×±º(úìäûÏØ)
  • phenolic group
    Æä³î±â(Ðñ)
  • phenolic hydroxyl group
    Æä³î ÇÏÀ̵å·Ï½Ç±â(Ðñ)
  • phosphate group
    Àλê±â(×òß«Ðñ)
  • phosphate group transfer
    Àλê±â ÀüÀÌ(×òß«Ðñï®ì¹)
  • phosphatidal group
    Æ÷½ºÆÄƼ´Þ±â(Ðñ)
  • phosphatidyl group
    Æ÷½ºÆÄƼµô±â(Ðñ)
  • phosphoryl group
    ÀλêÈ­±â(×òß«ûùÐñ)
  • phosphoryl-group carrier
    ÀλêÈ­±â ¿î¹Ýü(×òß«ûùÐñê¡Úæô÷)
  • phosphoryl-group transfer
    ÀλêÈ­±â ÀüÀÌ(×òß«ûùÐñï®ì¹)
  • prenyl group
    ÇÁ·¹´Ò±â(Ðñ)
  • prosthetic group
    º¸Á¶ ºÐÀÚÁ·(ÜÍð¾ÝÂí­ðé)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • anterior spinal artery
    Àüô¼öµ¿¸Æ
  • anterior tibial artery
    Àü°æ°ñµ¿¸Æ
  • anterior tubercle
    Àü°áÀý
  • commissura anterior
    ¾Õ±³Â÷¿¬°á, Àü±³·Ã
  • left anterior descending branch
    ÁÂÀüÇÏÇàÁö
  • left anterior oblique
    ÁÂÀü»çÀ§
  • nares anterior
    ¾ÕÄ౸¸Û, Àüºñ°ø
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CA anterior commissure [Lat. commissura anterior]; calcium antagonist; California [rabbit]; cancer; Can...
LADA laboratory animal dander allergy; left acromio-dorso-anterior [position]; left anterior descending a...
OA obstructive apnea; occipital artery; occipito-anterior; occiput anterior; octanoic acid; ocular albi...
Sa the most anterior point of the anterior contour of the sella turcica [point]; saline; Staphylococcus...
AFP Alpha(¥á) Feto-Protein [HP 1826, 1858, 1859, 2265]
  ; Oncofetal Antigens
 &nbs...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CSF Coronary sinus blood flow
CSF Coronary sinus flow
CSNRT Corrected Sinus Node Recovery Time
DP D. pteronys-sinus
EST Endodermal sinus tumor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pyriform sinus
    ¾ç¹è²Ã µ¿
  • ramus sinus caroticus
    ¸ñ µ¿¸Æµ¿ °¡Áö, °æµ¿¸Æµ¿Áö
  • renal sinus
    ½Åµ¿
  • rhomboid sinus
    Á¦»ç ³ú½Ç
  • sagittal sinus
    ½Ã»ó µ¿
  • septum of sphenoidal sinus
    Á¢Çüµ¿ Áß°Ý
  • sigmoid sinus
    ¿¡½ºÀÚ Á¤¸Æµ¿, S»ó Á¤¸Æµ¿
  • sinus anales
    Ç×¹®µ¿
    ÇÏ´Ü¿¡ ÁÖ¸Ó´Ï °°Àº ÇԿ並 °®°í ÀÖ´Â ±¸. Á÷ÀåÁÖ¸¦ ºÐ¸®½ÃŲ´Ù.
  • sinus arrhythmia
    µ¿ ºÎÁ¤¸Æ, µ¿¼º ºÎÁ¤¸Æ
  • sinus barotrauma
    ºÎºñ°­ ¾Ð·Â ¿Ü»ó, Ç×°ø ºÎºñ°­¿°
  • sinus caroticus
    °æ µ¿¸Æµ¿
    ³»°æ µ¿¸ÆÀÇ ÆØ´ëºÎ. ÃÑ°æ µ¿¸ÆÀÌ µÎ ºÐÁö·Î ³ª´µ´Â °÷ »ó¹æ¿¡ À§Ä¡Çϰųª, ÃѰ浿¸ÆÀÇ Á¾¸»ºÎ¿¡ À§Ä¡ÇÑ´Ù. º®¿¡´Â Ç÷¾ÐÀÇ º¯È­¿¡ ÀÇÇØ ÀڱصǴ ¾Ð·Â ¼ö¿ë±â°¡ ÀÖ´Ù.
  • sinus circularis
    À± Á¤¸Æµ¿
    Çϼöü ÁÖÀ§¿¡¼­ µÎ ÇØ¸é Á¤¸Æµ¿, Àü ¹× ÈÄ ÇØ¸é°£ Á¤¸Æµ¿¿¡ ÀÇÇØ Çü¼ºµÇ´Â °í¸® ¸ð¾çÀÇ Á¤¸Æ.
  • sinus coelomaticum
    ü°­µ¿
  • sinus coronarius
    °ü»ó Á¤¸Æµ¿
    Á½ɹæ°ú ÁÂ½É½Ç »çÀÌÀÇ °ü»ó±¸¿¡ ³õ¿© ÀÖÀ¸¸ç, ¿ì½É¹æÀ¸·Î °³±¸ÇÏ´Â ´ë½ÉÀå Á¤¸ÆÀÇ Á¾¸»ºÎ.
  • sinus durae matris
    °æÁú¸· Á¤¸Æµ¿, °æ¸· Á¤¸Æµ¿
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
group velocity <radiobiology> This is derived from the dispersion relation as Vgroup = dw/dk, the group velocity is the rate at which modulations or information within a wave travel through a given medium.
(09 Oct 1997)
methyl group A -CH3 group on a larger molecule. A carbon which is single-bonded to three hydrogens, and has one free bond to the rest of the molecule.
(09 Oct 1997)
middle group of mesenteric lymph nodes The mesenteric lymph nodes located along the intestinal (jejunal and ileal) branches of the superior mesenteric artery.
Synonym: nodi lymphatici superiores centrales, central mesenteric lymph nodes.
(05 Mar 2000)
phosphate group <chemistry> A phosphate group on a larger molecule, where the phosphorus is single bonded to each of the four oxygens, and the other bond of one of the oxygens is attached to the rest of the molecule.
This means that the entire group has a net negative charge of -3 (from the free second bonds on the oxygen atoms which are only bonded to the phosphorus atom). Often hydrogen atoms will be attached to the oxygens and sometimes double bonds between the phosphorus and an oxygen are present.
(31 Dec 1997)
clinical cooperative group A group of medical institutions cooperating to perform clinical research.
(16 Dec 1997)
MN blood group antigens <haematology, immunology> A pair of blood group antigens governed by genes that segregate independently of the ABO locus. The alleles are codominant and there are three types MM, NN and MN. Glycophorin has M or N activity and this is associated with oligosaccharides attached to the amino terminal portion of the molecule. M type glycophorin differs from N type in amino acid residues 1 and 5, although the antigenic determinants are associated with the carbohydrate side chains.
(18 Nov 1997)
MNSs blood group See Blood Groups appendix.
(05 Mar 2000)
mnss blood-group system A system of universal human blood group isoantigens with many associated subgroups. The m and n traits are codominant and the s and s traits are probably very closely linked alleles, including the u antigen. This system is most frequently used in paternity studies.
(12 Dec 1998)
collective group <zoology> An aggregate of related species of which the generic position is uncertain. According to the Code, for the sake of taxonomic convenience, may be treated as a genus.
Such a collective group does not require a type species. Assignment to a collective group is a temporary, convenient, identifying label.
(09 Jan 1998)
collective-group name 1. A name established expressly for a collective group.
2. A name established for a nominal genus or subgenus and later used for a collective group.
(09 Jan 1998)
wenlock group <geology> The middle subdivision of the Upper Silurian in Great Britain; so named from the typical locality in Shropshire.
Source: Websters Dictionary
(01 Mar 1998)
compatibility group <molecular biology> A group of plasmids (rings of DNA) which is able to coexist in the same cell with another plasmid from a different group.
(05 Jan 1998)
platinum group A group of six amphoteric elements: iridium, osmium, palladium, platinum, rhodium, and ruthenium.
(05 Mar 2000)
connective tissue group <physiology> A collective name for mucous tissue, dentin, bone, cartilage, and ordinary connective tissue, all derived from the mesenchyme.
(05 Mar 2000)
control group A group of subjects participating in the same experiment as another group of subjects, but which is not exposed to the variable under investigation.
See: experimental group.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á